What is the address of DR. R. ALGABA, CHIRURGIE?

The registered office of DR. R. ALGABA, CHIRURGIE is located at Breemputstraat 150, 1800 Vilvoorde.

Is DR. R. ALGABA, CHIRURGIE still active?

Yes. According to the CBE (17 September 2026) DR. R. ALGABA, CHIRURGIE is active, legal situation “Normale toestand”, started on 28 December 2006.

Is DR. R. ALGABA, CHIRURGIE registered on Peppol?

No, DR. R. ALGABA, CHIRURGIE is currently not registered on the Peppol network.

What is the enterprise number of DR. R. ALGABA, CHIRURGIE?

The enterprise number of DR. R. ALGABA, CHIRURGIE is BE0885984340.

When was DR. R. ALGABA, CHIRURGIE founded?

DR. R. ALGABA, CHIRURGIE was founded on 28 December 2006.

Who are the directors of DR. R. ALGABA, CHIRURGIE?

According to the 2025 annual accounts, the directors of DR. R. ALGABA, CHIRURGIE are: Robert Algaba.

Is DR. R. ALGABA, CHIRURGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 December 2006; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. R. ALGABA, CHIRURGIE make in 2025?

DR. R. ALGABA, CHIRURGIE recorded a loss after taxes of € 50,373 in financial year 2025.

What is the revenue of DR. R. ALGABA, CHIRURGIE?

As a small company, DR. R. ALGABA, CHIRURGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -27,489.

DR. R. ALGABA, CHIRURGIE (Private Limited) - Vilvoorde

Dossier DR. R. ALGABA, CHIRURGIE, printed on 17 September 2026 from databakkes.be/en/0885984340/dr-r-algaba-chirurgie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2023 and 2025.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR. R. ALGABA, CHIRURGIE from Vilvoorde, company number BE0885984340, closed financial year 2025 with a result of € -50,373 after tax. For that financial year DR. R. ALGABA, CHIRURGIE recorded a gross margin of € -27,489 and equity of € 614,364. Compared with financial year 2023, the result moved from € -35,914 to € -50,373. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 18, 2026.

What it is worth Healthy

€ 614,364

▼ 11% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -50,373

▼ 40 % more loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 3,559

▼ 84% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 174,364.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 17,568

▼ 23% vs 2023

€ 2,856 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 1,812

▼ 26% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 565

▲ 15% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2025	Change 2023 → 2025
Gross margin	€ -12,943 Gross margin 2021: € -12,943 First fiscal year in the series	€ -24,540 Gross margin 2022: € -24,540 ▼ € 11,597 vs 2021 (€ -12,943) Unfavourable step	€ -13,076 Gross margin 2023: € -13,076 ▲ € 11,464 vs 2022 (€ -24,540) Favourable step	€ -27,489 Gross margin 2025: € -27,489 ▼ € 14,413 vs 2023 (€ -13,076) Unfavourable step	▼ € 14,413
Profit after taxes	€ -55,544 Profit after taxes 2021: € -55,544 First fiscal year in the series	€ -59,704 Profit after taxes 2022: € -59,704 ▼ € 4,159 vs 2021 (€ -55,544) Unfavourable step	€ -35,914 Profit after taxes 2023: € -35,914 ▲ € 23,789 vs 2022 (€ -59,704) Favourable step	€ -50,373 Profit after taxes 2025: € -50,373 ▼ € 14,459 vs 2023 (€ -35,914) Unfavourable step	▼ € 14,459
Equity	€ 788,359 Equity 2021: € 788,359 First fiscal year in the series	€ 728,656 Equity 2022: € 728,656 ▼ 8% vs 2021 (€ 788,359) Unfavourable step	€ 692,741 Equity 2023: € 692,741 ▼ 5% vs 2022 (€ 728,656) Unfavourable step	€ 614,364 Equity 2025: € 614,364 ▼ 11% vs 2023 (€ 692,741) Unfavourable step	▼ 11%
Total debts	€ 54,611 Total debts 2021: € 54,611 First fiscal year in the series	€ 29,353 Total debts 2022: € 29,353 ▼ 46% vs 2021 (€ 54,611) Favourable step	€ 35,369 Total debts 2023: € 35,369 ▲ 20% vs 2022 (€ 29,353) Unfavourable step	€ 19,945 Total debts 2025: € 19,945 ▼ 44% vs 2023 (€ 35,369) Favourable step	▼ 44%
Cash	€ 70,504 Cash 2021: € 70,504 First fiscal year in the series	€ 38,984 Cash 2022: € 38,984 ▼ 45% vs 2021 (€ 70,504) Unfavourable step	€ 21,938 Cash 2023: € 21,938 ▼ 44% vs 2022 (€ 38,984) Unfavourable step	€ 3,559 Cash 2025: € 3,559 ▼ 84% vs 2023 (€ 21,938) Unfavourable step	▼ 84%
Land & buildings	€ 582,800 Land & buildings 2021: € 582,800 First fiscal year in the series	€ 568,400 Land & buildings 2022: € 568,400 ▼ 2% vs 2021 (€ 582,800) Unchanged	€ 554,000 Land & buildings 2023: € 554,000 ▼ 3% vs 2022 (€ 568,400) Unchanged	€ 525,200 Land & buildings 2025: € 525,200 ▼ 5% vs 2023 (€ 554,000) Unchanged	▼ 5%
Retained profit	€ 388,359 Retained profit 2021: € 388,359 First fiscal year in the series	€ 328,656 Retained profit 2022: € 328,656 ▼ 15% vs 2021 (€ 388,359) Unfavourable step	€ 292,741 Retained profit 2023: € 292,741 ▼ 11% vs 2022 (€ 328,656) Unfavourable step	€ 174,364 Retained profit 2025: € 174,364 ▼ 40% vs 2023 (€ 292,741) Unfavourable step	▼ 40%
Dividend	€ 50,000 Dividend 2021: € 50,000 First fiscal year in the series	€ 0 Dividend 2022: € 0 ▼ 100% vs 2021 (€ 50,000) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2021: € 0 First fiscal year in the series	€ 0 Bank debt 2022: € 0 Unchanged (€ 0) Unchanged	€ 22,936 Bank debt 2023: € 22,936 Unchanged (€ 0) Unfavourable step	€ 17,568 Bank debt 2025: € 17,568 ▼ 23% vs 2023 (€ 22,936) Favourable step	▼ 23%
Balance sheet total	€ 842,970 Balance sheet total 2021: € 842,970 First fiscal year in the series	€ 758,009 Balance sheet total 2022: € 758,009 ▼ 10% vs 2021 (€ 842,970) Unchanged	€ 728,110 Balance sheet total 2023: € 728,110 ▼ 4% vs 2022 (€ 758,009) Unchanged	€ 634,309 Balance sheet total 2025: € 634,309 ▼ 13% vs 2023 (€ 728,110) Unchanged	▼ 13%

Key figures of DR. R. ALGABA, CHIRURGIE, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. R. ALGABA, CHIRURGIE?

What happened at DR. R. ALGABA, CHIRURGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 18, 2026 New annual accounts for financial year 2025: loss of € 50,373. filed late Source: NBB ↗
Dec 28, 2006 Start of the company according to the CBE. KBO

In short

From € 55,544 loss in 2021 to € 50,373 loss in 2025.

Paid € 2,286 in corporate taxes since 2021.

Paid out € 50,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. R. ALGABA, CHIRURGIE? We notify you, reason included.

Follow DR. R. ALGABA, CHIRURGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Robert Algaba

DR. R. ALGABA, CHIRURGIE

Behind DR. R. ALGABA, CHIRURGIE is Robert Algaba.

See the full network in the app

Directors

According to the 2025 annual accounts

Robert Algaba

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Breemputstraat 150

1800 Vilvoorde

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0885.984.340
VAT number: BE 0885.984.340
Registered office: Breemputstraat 150, 1800 Vilvoorde
Names & denominations: DR. R. ALGABA, CHIRURGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 December 2006
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗